Please provide your email address to receive an email when new articles are posted on . Despite similar procedural success, percutaneous mitral valve repair for post-MI mitral regurgitation was ...
CHICAGO, IL—Eagerly awaited results from two percutaneous mitral valve edge-to-edge repair trials are finally cresting the horizon. It’s confirmed: MITRA-FR will be released at the 2018 European ...
Transcatheter edge-to-edge repair of tricuspid regurgitation appears to reduce mortality and heart failure hospitalizations in patients at high surgical risk, according to the largest series to look ...
TEWKSBURY, Mass.--(BUSINESS WIRE)--Mitralign, Inc., an innovative provider of percutaneous valve repair solutions, today announced that the U.S. Food and Drug Administration has granted ...
(Philadelphia, PA and New Orleans, Louisiana) – The Hospital of the University of Pennsylvania (HUP) is participating in a nationwide clinical trial of a new valve repair device that could replace ...
MINNEAPOLIS, MN—October 31, 2013—A Paravalvular regurgitation, or leakage, commonly affects valvular prostheses, particularly artificial valves placed percutaneously according to data presented at the ...
Mitralign Inc., a cardiovascular device company, today reported on the successful use of its technology to perform a percutaneous repair on a patient with tricuspid regurgitation (TR). Prof. Dr. med.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results